Skip to main content

and
  1. Article

    Open Access

    Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia

    Little is known about the impact of DNA methylation on the evolution/progression of Ph+ chronic myeloid leukemia (CML). We investigated the methylome of CML patients in chronic phase (CP-CML), accelerated phas...

    G Heller, T Topakian, C Altenberger, S Cerny-Reiterer, S Herndlhofer, B Ziegler in Leukemia (2016)

  2. No Access

    Article

    High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia

    We investigated the pattern of lipoprotein lipase (LPL) expression in B-cell chronic lymphocytic leukemia (B-CLL) and assessed its prognostic relevance. Expression of LPL mRNA as well as protein was highly res...

    D Heintel, D Kienle, M Shehata, A Kröber, E Kroemer, I Schwarzinger in Leukemia (2005)

  3. No Access

    Article

    Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)

    The prognostic value of the detection of peripheral blood (PB) and/or bone marrow (BM) involvement by polymerase chain reaction (PCR) amplification of rearranged immunoglobulin heavy chain (IgH) and immunoglob...

    G Mitterbauer-Hohendanner, C Mannhalter, K Winkler, M Mitterbauer, C Skrabs in Leukemia (2004)

  4. No Access

    Article

    High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia

    Activation-induced cytidine deaminase (AID) is essential for somatic hypermutation of B-cells. We investigated the expression of AID mRNA by real-time polymerase chain reaction (PCR) in peripheral blood mononu...

    D Heintel, E Kroemer, D Kienle, I Schwarzinger, A Gleiß, J Schwarzmeier in Leukemia (2004)

  5. No Access

    Article

    Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome

    To define reproducible criteria for subgroups of diffuse large B-cell lymphomas (DLBCL), including lymphomas with plasmablastic/plasmacytoid features (PB/PC-Fs), we investigated 66 DLBCL; the samples were cate...

    I Simonitsch-Klupp, I Hauser, G Ott, J Drach, J Ackermann, J Kaufmann in Leukemia (2004)

  6. No Access

    Article

    Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge

    C Skrabs, C Müller, H Agis, C Mannhalter, U Jäger in Leukemia (2002)

  7. No Access

    Article

    Alternative end-joining in follicular lymphomas’ t(14;18) translocation

    T(14;18) chromosomal translocation is assumed to result from illegitimate rearrangement between the BCL2 proto-oncogene and the IGH locus during the DH to JH joining phase of V(D)J recombination in early B cells....

    R Marculescu, T Le, S Böcskör, G Mitterbauer, A Chott, C Mannhalter, U Jaeger in Leukemia (2002)

  8. No Access

    Article

    Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma

    From 1987 to 1999 35 patients with poor prognosis non-Hodgkin's lymphoma (NHL) underwent allogeneic stem cell transplantation (SCT) at the University Hospitals of Vienna and Graz. Initial biopsy specimens were...

    M Mitterbauer, P Neumeister, P Kalhs, S Brugger, G Fischer, K Dieckmann in Leukemia (2001)

  9. No Access

    Article

    Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

    We analyzed toxicity and efficacy of chemotherapy (CT) or second stem cell transplantation (SCT) and/or immunotherapy defined as stop of immunosuppression (IS) or donor leukocyte infusion (DLI) in 47 patients ...

    F Keil, E Prinz, P Kalhs, K Lechner, K Moser, I Schwarzinger, U Jäger in Leukemia (2001)

  10. No Access

    Article

    Evaluation of a highly specific functional test for the detection of factor V Leiden

    In the present study, a new functional test for the detection of increased resistance of coagulation factor V to degradation by activated protein C (factor V Leiden mutation) was evaluated. The STA-STACLOT APC...

    P. Quehenberger, S. Handler, C. Mannhalter in International Journal of Clinical and Labo… (2000)

  11. No Access

    Article

    Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR

    Twenty-seven patients with AML and MLL gene rearrangement were analyzed by a reverse transcriptase polymerase chain reaction (RT-PCR) for the MLL-AF9 translocation. The MLL-AF9 fusion transcript was detected in s...

    G Mitterbauer, C Zimmer, C Fonatsch, OA Haas, R Thalhammer-Scherrer in Leukemia (1999)

  12. No Access

    Article

    Genetic fingerprinting in mouthwashes of patients after allogeneic bone marrow transplantation

    Detection of chimerism by PCR analysis of short tandem repeats (STR) in blood samples of patients who received allogeneic bone marrow transplantation (BMT) has proved to be an important method for early detect...

    G Endler, H Greinix, K Winkler, G Mitterbauer, C Mannhalter in Bone Marrow Transplantation (1999)

  13. No Access

    Article

    Low transplant-related mortality in patients receiving unrelated donor marrow grafts for leukemia

    Transplantation with unrelated donor (UD) marrow has been shown to potentially cure patients with leukemia. Between January 1991 and April 1998, 54 patients with leukemia have received an UD BMT at our institu...

    P Kalhs, S Brugger, E Reiter, F Keil, G Fischer in Bone Marrow Transplantation (1999)

  14. No Access

    Article

    Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia

    The WT1 gene is expressed in 73–100% of patients with acute myelogenous leukemia (AML) and is thought to play a role in maintaining the viability of leukemic cells. WT1 has been proposed as a marker for minima...

    A Gaiger, D Schmid, G Heinze, B Linnerth, H Greinix, P Kalhs, K Tisljar in Leukemia (1998)

  15. No Access

    Article

    Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis

    Among 379 patients with AML with FAB type M1, 2 and M4–7 diagnosed between 1978 and 1997 in our institution, 19 (5%) had hypofibrinogenemia (HF), ie a fibrinogen level <180 mg/dl. compared to patients with nor...

    A Weltermann, I Pabinger, K Geissler, U Jäger, H Gisslinger, P Knöbl in Leukemia (1998)

  16. No Access

    Article

    Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors

    Between April 1982 and February 1997 39 patients (24 male, 15 female) with refractory acute leukemia and a median age of 31 years (19–51 years) received allogeneic marrow grafts from an HLA-identical sibling (n =...

    HT Greinix, E Reiter, F Keil, G Fischer, K Lechner in Bone Marrow Transplantation (1998)

  17. No Access

    Article

    Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia

    We examined the presence of WT1-specific mRNA in bone marrow samples of 125 patients with de novo acute myeloid leukemia at diagnosis by two-step RT-PCR. The sensitivity of the assay was 1:100 (first step) and 1:...

    D Schmid, G Heinze, B Linnerth, K Tisljar, R Kusec, K Geissler, C Sillaber in Leukemia (1997)